Home » Topics » BioWorld Science

BioWorld Science
RSS

Recruitment open for phase IIa study of Nerofe for AML and MDS

July 13, 2018

Roche presents phase II data for olesoxime in patients with SMA

July 13, 2018

Shenzhen Chipscreen Biosciences patents indoleamine 2,3-dioxygenase 1 inhibitors

July 13, 2018

Lilly presents IDH1 and IDH2 mutant inhibitors

July 13, 2018

N-Acetyl-beta-D-glucosaminidase inhibitors identified at Janssen

July 13, 2018

Ono Pharmaceutical initiates phase I study of ONO-5788

July 13, 2018

Audentes Therapeutics presents phase I/II data on AT-132 for XLMTM

July 13, 2018

Positive topline data presented from second pivotal phase III study of ZX-008 in Dravet Syndrome

July 13, 2018

Yale University develops novel SV2A radiotracer for PET imaging of synaptic density

July 13, 2018

Astellas' phase I study of ASP-1948 in advanced solid tumors enrolling patients

July 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...